ReviewUnited European gastroenterology journal2026
Changing the Flow: How EUS-Guided Drainage is Reshaping the Management of Distal Malignant Biliary Obstruction.
Review in United European gastroenterology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- UEG Journal-In Times of Turmoil, Science Matters.United European gastroenterology journal · 2026Article
- Changing the Flow: How EUS-Guided Drainage is Reshaping the Management of Distal Malignant Biliary Obstruction.United European gastroenterology journal · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endoscopic ultrasound-guided biliary drainage (EUS-BD) has evolved from a rescue therapy into a viable alternative to endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous drainage for distal malignant biliary obstruction (dMBO). Among the available techniques, EUS-guided choledochoduodenostomy (EUS-CDS) has become the preferred approach, supported by expanding evidence, and wider adoption beyond expert centres. EUS-guided hepaticogastrostomy (EUS-HGS) currently retains a role in high-volume centres and in patients with combined biliary and duodenal obstruction, while other approaches, including EUS-guided gallbladder drainage, antegrade stenting, and rendezvous procedures, are applied selectively due to limited evidence or narrower applicability. This review summarizes the current role of EUS-BD in dMBO, with emphasis on EUS-CDS. Technical and clinical considerations, training requirements, and remaining challenges are discussed, and future perspectives are outlined, focusing on device innovation and patient-centred outcomes to guide safe and structured integration of EUS-BD into clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.